Stocks TelegraphStocks Telegraph
Stock Ideas

HALO Financial Statements and Analysis

NASDAQ : HALO

Halozyme Therapeutics, Inc.

$57.33
0.56+0.99%
Open: 1:52 PM
59.61
BESG ScoreESG Rating

HALO FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

HALO Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue290.084M231.353M195.879M230.039M216.033M
cost of revenue49.426M57.369M46.092M52.298M54.823M
gross profit240.658M173.984M149.787M177.741M161.21M
gross profit ratio0.830.7520.7650.7730.746
research and development expenses18.458M21.038M19.111M21.336M17.321M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses41.241M35.711M35.134M37.608M35.269M
other expenses17.762M17.762M17.763M17.762M20.341M
operating expenses77.461M56.749M54.245M76.706M72.931M
cost and expenses126.887M114.118M100.337M129.004M127.754M
interest income00003.549M
interest expense4.524M4.524M4.507M5.22M4.505M
depreciation and amortization20.362M20.362M20.206M20.693M20.341M
ebitda190.033M137.597M115.748M121.728M108.62M
ebitda ratio0.6550.5950.5910.5290.503
operating income163.197M117.235M95.542M101.035M88.279M
operating income ratio0.5630.5070.4880.4390.409
total other income expenses net1.95M508.00K486.00K5.36M17.986M
income before tax165.147M117.743M96.028M101.175M101.76M
income before tax ratio0.5690.5090.490.440.471
income tax expense28.136M24.498M19.205M15.787M19.923M
net income137.011M93.245M76.823M85.388M81.837M
net income ratio0.4720.4030.3920.3710.379
eps1.080.730.610.660.62
eps diluted1.050.720.600.650.61
weighted average shs out126.85M127.116M126.941M129.054M131.965M
weighted average shs out dil130.134M129.222M128.887M131.035M134.083M
Graph

HALO Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents154.318M187.864M164.627M118.37M274.227M
short term investments511.988M341.166M298.824M217.63M209.055M
cash and short term investments666.306M529.03M463.451M336.00M483.282M
net receivables285.743M214.524M195.902M234.21M217.325M
inventory131.412M159.312M168.541M127.601M128.921M
other current assets43.515M84.931M45.69M48.613M49.478M
total current assets1.127B987.797M873.584M746.424M879.006M
property plant equipment net74.49M75.00M78.071M74.944M74.669M
goodwill416.821M416.821M416.821M416.821M416.821M
intangible assets419.592M437.354M455.116M472.879M490.641M
goodwill and intangible assets836.413M854.175M871.937M889.70M907.462M
long term investments0200.00K300.00K00
tax assets00616.00K4.386M13.41M
other non current assets80.151M52.281M17.019M17.816M18.115M
total non current assets991.054M981.656M967.943M986.846M1.014B
other assets00000
total assets2.118B1.969B1.842B1.733B1.893B
account payables12.398M15.43M13.325M11.816M19.318M
short term debt00032.197M32.358M
tax payables029.265M19.074M963.00K18.029M
deferred revenue029.265M19.074M-32.197M667.00K
other current liabilities96.417M88.665M99.24M100.678M62.842M
total current liabilities108.815M133.36M131.639M112.494M115.185M
long term debt1.504B1.533B1.532B1.499B1.498B
deferred revenue non current0-1.00002.253M
deferred tax liabilities non current11.952M13.647M000
other non current liabilities40.406M0037.72M28.422M
total non current liabilities1.557B1.547B1.532B1.537B1.528B
other liabilities01.00000
capital lease obligations030.664M31.763M00
total liabilities1.665B1.68B1.664B1.649B1.643B
preferred stock00000
common stock127.00K127.00K127.00K127.00K132.00K
retained earnings397.629M260.618M167.373M90.55M222.285M
accumulated other comprehensive income loss-6.939M-2.068M-1.486M-9.278M1.227M
other total stockholders equity61.886M30.747M11.794M2.409M25.537M
total stockholders equity452.703M289.424M177.808M83.808M249.181M
total equity452.703M289.424M177.808M83.808M249.181M
total liabilities and stockholders equity2.118B1.969B1.842B1.733B1.893B
minority interest00000
total investments511.988M341.366M299.124M217.63M209.055M
total debt1.504B1.533B1.533B1.499B1.498B
net debt1.35B1.345B1.368B1.381B1.223B
Graph

HALO Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax292.00K14.241M1.291M9.423M9.702M
stock based compensation12.578M9.471M9.874M9.664M9.368M
change in working capital60.707M-82.262M21.555M-26.096M22.086M
accounts receivables-71.22M-18.621M38.308M-16.885M28.853M
inventory1.98M-21.402M-40.233M1.469M3.634M
accounts payables-21.878M018.685M11.46M0
other working capital18.759M-42.239M23.48M-22.14M-10.401M
other non cash items-115.541M90.955M51.889M3.282M-13.66M
net cash provided by operating activities115.376M55.794M129.427M102.354M132.411M
investments in property plant and equipment-1.517M-2.582M-3.545M-2.596M-2.944M
acquisitions net000080.506M
purchases of investments-303.974M-93.42M-198.763M-21.294M-161.698M
sales maturities of investments138.008M53.963M119.627M15.599M81.192M
other investing activites0-39.457M-79.136M0-80.506M
net cash used for investing activites-167.483M-42.039M-82.681M-8.291M-83.45M
debt repayment000-13.483M0
common stock issued19.05M8.993M-489.00K8.927M4.101M
common stock repurchased489.00K0-489.00K-252.30M0
dividends paid000-13.483M0
other financing activites-978.00K489.00K-489.00K20.419M4.101M
net cash used provided by financing activities18.561M9.482M-489.00K-249.92M4.101M
effect of forex changes on cash00000
net change in cash-33.546M23.237M46.257M-155.857M53.062M
cash at end of period154.318M187.864M164.627M118.37M274.227M
cash at beginning of period187.864M164.627M118.37M274.227M221.165M
operating cashflow115.376M55.794M129.427M102.354M132.411M
capital expenditure-1.517M-2.582M-3.545M-2.596M-2.944M
free cash flow113.859M53.212M125.882M99.758M129.467M
Graph

Frequently Asked Questions

How did Halozyme Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, HALO generated $290.08M in revenue last quarter, while its costs came in at $49.43M.

Last quarter, how much Gross Profit did Halozyme Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Halozyme Therapeutics, Inc. reported a $240.66M Gross Profit for the quarter ended Sep 30, 2024.

Have HALO's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. HALO incurred $77.46M worth of Operating Expenses, while it generated $163.20M worth of Operating Income.

How much Net Income has HALO posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Halozyme Therapeutics, Inc., the company generated $137.01M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Halozyme Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Halozyme Therapeutics, Inc. as of the end of the last quarter was $154.32M.

What are HALO's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, HALO had Total Net Receivables of $285.74M.

In terms of Total Assets and Current Assets, where did Halozyme Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of HALO were $1.13B, while the Total Assets stand at $2.12B.

As of the last quarter, how much Total Debt did Halozyme Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of HALO's debt was $1.50B at the end of the last quarter.

What were HALO's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, HALO reported total liabilities of $1.67B.

How much did HALO's Working Capital change over the last quarter?

Working Capital Change for HALO was $60.71M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

HALO generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. HALO generated $115.38M of Cash from Operating Activities during its recently reported quarter.

What was HALO's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. HALO reported a -$33.55M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph